What is the current Protalix BioTherapeutics share price?
The current share price of Protalix BioTherapeutics is US$ 1.76
How many Protalix BioTherapeutics shares are in issue?
Protalix BioTherapeutics has 73,633,583 shares in issue
What is the market cap of Protalix BioTherapeutics?
The market capitalisation of Protalix BioTherapeutics is USD 128.12M
What is the 1 year trading range for Protalix BioTherapeutics share price?
Protalix BioTherapeutics has traded in the range of US$ 0.8214 to US$ 1.90 during the past year
What is the PE ratio of Protalix BioTherapeutics?
The price to earnings ratio of Protalix BioTherapeutics is 15.5
What is the cash to sales ratio of Protalix BioTherapeutics?
The cash to sales ratio of Protalix BioTherapeutics is 1.97
What is the reporting currency for Protalix BioTherapeutics?
Protalix BioTherapeutics reports financial results in USD
What is the latest annual turnover for Protalix BioTherapeutics?
The latest annual turnover of Protalix BioTherapeutics is USD 65.49M
What is the latest annual profit for Protalix BioTherapeutics?
The latest annual profit of Protalix BioTherapeutics is USD 8.31M
What is the registered address of Protalix BioTherapeutics?
The registered address for Protalix BioTherapeutics is 108 W. 13TH STREET, SUITE 100, WILMINGTON, DELAWARE, 19801
What is the Protalix BioTherapeutics website address?
The website address for Protalix BioTherapeutics is protalix.com
Which industry sector does Protalix BioTherapeutics operate in?
Protalix BioTherapeutics operates in the MANAGEMENT SERVICES sector
Register for real-time alerts, custom portfolio, and market movers
Hot Features
Premium
